RecTech

[Lukas T. Schmitt @LukasTSchmitt]

Thank you for having me! It was great presenting at #AGD2022

[RecTech @RecTech_Dresden]

Our CSO and Co-founder @felix_lansing was awarded with one of the most highly endowed prizes in Germany by the @KoerberScience for his PhD work about Designer-Recombinases. Congratulations as well to the @BuchholzLab_TUD @tudresden_de where this technology has its origin.

[KoerberScience @KoerberScience]

Beyond #CRISPR: Felix Lansing @tudresden_de hat ein neues molekulares Skalpell zur Behandlung genetischer Krankheiten entwickelt. Für seine Promotion erhält er den Deutschen #Studienpreis 2022. Herzlichen Glückwunsch @felix_lansing! https://t.co/Ztj3lN99Nc

[Buchholz Lab @BuchholzLab_TUD]

We are happy to attend FASEB's Genome Engineering Conference! We hope everyone enjoyed Frank's talk about the swiss knife of the genome editing tools on Monday. If you want to learn more, check out our posters 16 (@Jacafaca_) and 25 (@MLiliya_) tonight!
#GECSRC22 @FASEBorg

[RecTech @RecTech_Dresden]

Thanks for featuring us! We are happy to win the voting for the startup newcomer of the week!

[startupdetector 🚀🔎 @startupdetect]

#WeeklyUpdate Startup-Woche 16-2022:

🚀 38 neue #Startups
🌷 24% #FemaleFounders
💸 34 Startups mit frischem #VentureCapital

🎉 Unsere Neugründungen der Woche:
@RecTech_Dresden

🎉 Unser Investment der Woche:
https://t.co/R7USZGkvEj

[RecTech @RecTech_Dresden]

Yesterday we founded RecTech GmbH (i. Gr.)! This is a big step forward on the way to develop designer recombinases for clinical applications. All of it wouldn't be possible without such a great team @BuchholzLab_TUD. Looking forward to the exciting times ahead!

[RecTech @RecTech_Dresden]

Thanks for sharing the amazing work happening in the Buchholz Lab! @BuchholzLab_TUD @Medizin_TUD @tudresden_de

[Buchholz Lab @BuchholzLab_TUD]

It was a pleasure to present our research in the annual meeting of the German Society for Gene Therapy (DG-GT) 🧬@DGGTeV #GeneTherapy

[RecTech @RecTech_Dresden]

Great work @felix_lansing! Designer-recombinases for treating Hemophilia A caused by large gene inversions! #gth2022 https://t.co/mbSUYHXHMp

[Felix Lansing @felix_lansing]

It was a great pleasure to present our recently published paper (https://t.co/xJeE6f5FC5) at the 66th @AnnualGth 2022.
It was my first talk in person since more than 2 years! Thanks for the great event!
Work from: @BuchholzLab_TUD @TakebeLab @Medizin_TUD @digsbb @tudresden_de

[Tigem Telethon @Tigem_Telethon]

🗞️#UpgradeH2020 publication by @felix_lansing @BuchholzLab_TUD on developing a designer-recombinase to treat #iPSC-derived #endothelial cells to correct a Factor VIII #genomic inversion often found in patients with severe #Hemophilia A 🧬
@Telethonitalia
https://t.co/pwkluxricB

[RecTech @RecTech_Dresden]

Great news! @RecTech_Dresden has been selected as one of the #Top50Startups. We are very happy for this achievement and look forward to 2022. Check out the ranking! 👇
https://t.co/x6flcleGMT

[RecTech @RecTech_Dresden]

Evolved recombinases can invert a 140 kb(!) DNA fragment that is causative for severe #Hemophilia A. We are looking forward to unlock the full potential of theses enzymes here at @RecTech_Dresden! Congratulations to @felix_lansing and the @BuchholzLab_TUD
https://t.co/mbSUYHXHMp

[RecTech @RecTech_Dresden]

@FrankBuchholz19 and @felix_lansing form the @BuchholzLab_TUD will be talking at the @ESGCT Virtual Congress this week! Be thrilled to hear about recombinases and their potential use for gene therapy! #recombinases #GeneTherapy #RecTech

[Felix Lansing @felix_lansing]

Today the @ESGCT Virtual Congress will start! I am excited to hear about many new approaches from the fields of gene and cell therapy! On top, I will give my very first talk at a scientific conference on Thursday at 5.30pm CEST!
#esgct2021 #recombinases #GeneTherapy

[RecTech @RecTech_Dresden]

We had a great time and were honored to pitch at this event. Check it out here: https://t.co/zyKusc6o9d

[RecTech @RecTech_Dresden]

Thanks for organizing such an event and giving us the opportunity to pitch!

[HTGF @HTGF]

Another five #startups pitched their innovative ideas to renowned investors at the LIFE SCIENCE PITCH DAY.💯Great pitches by: RecTec, @OPSYON_CD47, Invasight, Riana Therapeutics and Dimericon. #HTGF #LifeScience #PitchDay @Bayer, @BoehringerDE, IZB

[RecTech @RecTech_Dresden]

Are you curious about what we do at RecTech - Precision Genome Surgery and why? Take 30 sec and listen to our short video created at the @Science4Life_eV business competition! (German)

[RecTech @RecTech_Dresden]

We are happy to share that we won the second place in the business plan competition organized by @Science4Life_eV. But the experience we have gathered during the 4 days of workshops, networking and coaching are the true reward!
Info: https://t.co/S3n8uSsCE8

[RecTech @RecTech_Dresden]

If you want to watch the pitch follow this link: https://t.co/sj2DW9oSr4

[RecTech @RecTech_Dresden]

We are happy to announce that we have been selected as one of the winners of the Science4Life TechSlam!
We participated among 20 excellent teams and convinced in the category Pharma&Diagnostics!

[Buchholz Lab @BuchholzLab_TUD]

Thanks a lot for the opportunity to present our collaborative work with @ThomaKressLab at the Institute of Virology @UniFAU
Great talk, Teresa and Sebastian! 🎉🧬🔬
#HTLV #collaboration #Science

[RecTech @RecTech_Dresden]

Now its even more official! We have received the Award (digital) from @Science4Life_eV for winning the concept phase last Tuesday! Thanks again for organizing such a great event with many promising start-ups!

[RecTech @RecTech_Dresden]

@energiekoppler @Science4Life_eV @BuchholzLab_TUD Das stimmt! Euch auch nochmal herzlichen Glückwunsch von unserer Seite! Wenn's wieder möglich ist müssen wir uns unbedingt persönlich in Dresden treffen!

[RecTech @RecTech_Dresden]

After two days of great workshops and intense coaching we are happy to announce that RecTech was one of the winners from yesterdays @Science4Life_eV Concept Phase! Thanks to every one involved and the continuous support from the @BuchholzLab_TUD!
Details: https://t.co/PqqAU56uz5